Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Pathological Phenotype to Determine Optimal Management for Moderate to Severe Preschool Wheeze

NCT02517099 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT02517099
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02517099 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Pathological Phenotype to Determine Optimal Management for Moderate to Severe Preschool Wheeze
Lead sponsor
Imperial College London
Phase
Phase 2
Overall status
Completed
Start date
June 5, 2015
Completion date
August 17, 2018
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma